Product Images Exjade

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Exjade NDC 0078-0470 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Deferasirox structural formula. - exjade 01

Deferasirox structural formula. - exjade 01

Figure 1. Changes in Liver Iron Concentration and Serum Ferritin Following EXJADE (5 30 mg/kg per day) in Study 1. - exjade 02

Figure 1.  Changes in Liver Iron Concentration and Serum Ferritin Following EXJADE (5 30 mg/kg per day) in Study 1. - exjade 02

This appears to be a table or chart displaying information related to liver iron content and serum ferritin levels in relation to dosage of a medication called EXJADE®. The table displays different measurements for liver iron content and serum ferritin before and after treatment with EXJADE® at different dosages (in mg/kg/day). It is not possible to provide a more detailed description without additional context.*

PRINCIPAL DISPLAY PANEL – PACKAGE LABEL – 125 MG TABLETS - exjade 03

PRINCIPAL DISPLAY PANEL – PACKAGE LABEL – 125 MG TABLETS - exjade 03

PRINCIPAL DISPLAY PANEL – PACKAGE LABEL – 250 MG TABLETS - exjade 04

PRINCIPAL DISPLAY PANEL – PACKAGE LABEL – 250 MG TABLETS - exjade 04

PRINCIPAL DISPLAY PANEL – PACKAGE LABEL – 500 MG TABLETS - exjade 05

PRINCIPAL DISPLAY PANEL – PACKAGE LABEL – 500 MG TABLETS - exjade 05

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.